This conference will address the latest advances in the development of antivirals and other therapeutics for use against COVID-19 and possibilities for improved clinical management.
ABSTRACT SUBMISSION DEADLINE - FRIDAY 11TH SEPTEMBER
Submit your Abstract for oral or poster presentation here . Abstracts for both pre-clinical and clinical research are most welcome, additionally in any of these categories:
COVID-19 Clinical Spectrum
COVID-19 Viral Replication Kinetics
COVID-19 Immunopathogenesis
SARS-CoV-2 Antivirals
Immunomodulators
Pre-clinical studies
Clinical trial outcomes
Monoclonal and polyclonal antibodies, convalescent plasma
Combination Therapy Approaches
Best abstract presentations to be awarded.
Abstracts accepted for e-poster presentation will also have the opportunity to record a short 3-5 minute talk summarising the key points of their research
Register and submit your abstract today.
If any further details are required, please email lidadesouza@isirv.org
